FindTrial
Sign In

To check that how much reliable and cross adaptation in different culture of the Gujarati version of the scale used to assess Hip Disability and Osteoarthritis outcome score in patient with Hip condition

To Evaluate the Reliability and Cross Cultural Adaptation of Gujarati version of the Hip Disability and Osteoarthritis Outcome Score - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075921
Enrollment
120
Registered
2024-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Control Intervention1: Reliability and cross-cultural adaptation: Translation of English version of Hip Disability and Osteoarthritis Outcome Score (HOOS) into Gujarati version and will check the reli

Sponsors

Hansoti Nerin Navinchandra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 20 years and above Participants of both genders (male and female) will be included Diagnosed with any Hip surgery Indications for primary THA Subjects who will sign consent form willingly Participants who can understand Gujrati language

Exclusion criteria

Exclusion criteria: Patient suffering from Cerebrovascular storke patient suffering from parkinsons disease patient suffering from paraplegia

Design outcomes

Primary

MeasureTime frame
Reliability of Gujarati version of Hip Disability and Osteoarthritis Outcome ScoreTimepoint: 4 weeks—

Secondary

MeasureTime frame
Reliability of Gujarati version of Hip Disability and Osteoarthritis Outcome ScoreTimepoint: 1 day last day of 4 weeks—

Countries

India

Contacts

Public ContactDharmang Vyas

Parul Institute of Physiotherapy

prachi.choksi88@gmail.com7574861708

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026